Drug recall · May 18, 2016
Brevibloc DOUBLE STRENGTH Premixed Injection recall
Why: Discoloration: presence of atypical yellow discoloration of the solution .
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Brevibloc DOUBLE STRENGTH Premixed Injection, Esmolol Hydrochloride in Sodium Chloride, 2000mg/100mL (20 mg/mL), 100 mL, Rx only, Manufactured by Baxter Healthcare Corporation, Deerfield, Il 60015, NDC 10019-075-87
- Lots / codes
Lot # C989954, Exp 9/17
- Quantity
- 11,630 babs
- Company
- Baxter Healthcare Corp., Deerfield, IL
- Distribution
- Nationwide
- Initiated
- April 12, 2016 · Voluntary: Firm initiated
- Classified
- May 12, 2016
- Reported
- May 18, 2016
- Ended
- March 20, 2017
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Esmolol
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.